Marcos Antezana, M.D.
NPI 1104892843 · Dermatology Physician · Seattle, WA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1104892843
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- MD00042205 (WA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
20 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
5,073 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,732 | $8 |
| Test for Allergy Using Skin Patch95044 | 754 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 699 | $100 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 494 | $64 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 393 | $140 |
| Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305 | 196 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 28 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 126 | 58 |
| Triamcinolone Acetonide | 107 | 79 |
| Clobetasol Propionate | 91 | 45 |
| Mometasone Furoate | 78 | 42 |
| Fluocinonide | 73 | 36 |
| Metronidazole | 50 | 38 |
| Minoxidil | 36 | — |
| Fluorouracil | 33 | 28 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-02-23
- Last updated
- 2026-04-17
- Certified
- 2026-04-17
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.